Metabolomic Diagnostics is delighted to announce that CEO Robin Tuytten will present "The Biomarker Multiplexing Capabilities Of LC-MS Technology: The Key to Unlock Personalised Preeclampsia Risk Prediction Early in Pregnancy" for the American Association for Clinical Chemistry (AACC) on Jan 27th 2021. AACC is a global [...]
Metabolomic Diagnostics Little Island Cork, Ireland Metabolomic Diagnostics, the Ireland based deep tech medical diagnostics company, today announced the completion of a further venture capital funding round and the appointment of Dr. Robin Tuytten to the position of Chief Executive. The investment is led by [...]
SENIOR SCIENTIST MASS SPECTROMETRIST BIOMARKER VERIFICATION AND VALIDATION Project/Job Description Metabolomic Diagnostics Ltd is an early stage biotechnology company located in Cork, Ireland. The company is developing novel and innovative tests to predict pregnancy related complications prior to their clinical manifestation. The technology is [...]
Attendance at SDMD Global 2020 Mr. Diarmuid Cahalane, Co-Founder & Director of Regulatory Affairs, Metabolomic Diagnostics will present at Software Design for Medical Devices Global (SDMD) forum in Berlin (17th -20th Feb 2020). This 10th annual event is dedicated to medical device software design, [...]
Mr Charles Garvey, CEO of Metabolomic Diagnostics will be attending the Society of Maternal Fetal Medicine (SMFM) Pregnancy meeting next week in Texas, USA. The SMFM is a non-profit, membership organisation based in the US with more than 3,500 physicians, scientists and women’s health [...]